Raymond James upgraded shares of Cavium, Inc (NASDAQ:CAVM) from an outperform rating to a strong-buy rating in a report issued on Friday. They currently have $70.00 target price on the stock, up from their previous target price of $60.00. Cavium, Inc. (NASDAQ:CAVM) in last trading activity moved up 2.84% to close at $56.81. Company weekly performance is 5.85% while its quarterly performance stands at 2.67%. Cavium, Inc. (NASDAQ:CAVM) is 0.37% away from its 52 week high.
Altria Group Inc. (NYSE:MO) EVP John R. Nelson sold 1,640 shares of the stock on the open market in a transaction that occurred on Monday, November 17th. The shares were sold at an average price of $49.06, for a total transaction of $80,458.40. Following the transaction, the executive vice president now directly owns 407,288 shares of the company’s stock, valued at approximately $19,981,549. On last trading day Altria Group Inc. (NYSE:MO) moved up 0.53% to close at $49.72. Its volatility for the week is 0.86% while volatility for the month is 1.17%. MO’s sales growth for past 5 years was 4.80% and its EPS growth for past 5 years was 8.80%. Altria Group Inc. (NYSE:MO) monthly performance is 4.61%.
On 20 November Research Frontiers Inc. (NASDAQ:REFR) reported a loss of $640,000, or 3 cents per share, in its third quarter. The company, based in Woodbury, New York, posted revenue of $453,000 in the period. On last trading day Research Frontiers Inc. (NASDAQ:REFR) moved up 0.59% to close at $5.13. Its volatility for the week is 3.76% while volatility for the month is 3.98%. REFR’s sales growth for past 5 years was 5.30% and its EPS growth for past 5 years was -8.00%. Research Frontiers Inc. (NASDAQ:REFR) monthly performance is -0.97%.
On 19 November Ocean Shore Holding Co. (NASDAQ:OSHC) announced that the Company’s board of directors has approved the repurchase of up to 130,000 shares of the Company’s outstanding common stock, which is approximately 2% of outstanding shares. The Company completed its previously announced stock repurchase program for the purchase of 135,000 shares. Purchases will be conducted solely through a Rule 10b5-1 repurchase plan with Sandler O’Neill & Partners, L.P. Purchases will be based upon the parameters of the Rule 10b5-1 repurchase plan. Ocean Shore Holding Co. (NASDAQ:OSHC) has 1.10% insider ownership while its institutional ownership stands at 43.10%. In last trading activity company’s stock closed at $13.97.
On 4 November Sorrento Therapeutics Inc. (NASDAQ:SRNE) issued its quarterly earnings data on Tuesday. The company reported ($0.27) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.32) by $0.05. The company had revenue of $1.28 million for the quarter. On Wednesday shares of Sorrento Therapeutics, Inc. (NASDAQ:SRNE) closed at $3.80.